Immunology and Infectious Disease: 3 (Molecular & Cellular Biology of Critical Care Medicine)
Immunology and Infectious Disease: 3 (Molecular & Cellular Biology of Critical Care Medicine) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Genuine Products Guarantee
Genuine Products Guarantee
We guarantee 100% genuine products, and if proven otherwise, we will compensate you with 10 times the product's cost.
Delivery and Shipping
Delivery and Shipping
Products are generally ready for dispatch within 1 day and typically reach you in 3 to 5 days.
Immunology and Infectious Disease: 3 (Molecular & Cellular Biol...
Author: Doughty, Lesley A.
Brand: Springer
Edition: 2003 ed.
Binding: hardcover
Format: Illustrated
Number Of Pages: 276
Release Date: 31-12-2002
Part Number: 9781402073076
Details: Individualized dosing regimens specific to the patient, infection, bacteria, and antibiotic can optimize outcome. Integration of pharmacokinetic and pharmacodynamic data, called dual individualization, can be accomplished through the use of AUIe. AUIC dosing has been shown to predict bacteriological outcomes, hasten clinical outcomes, reduce the emergence of resistance, and be cost-effective. MPC dosing has been shown to predict the emergence of resistant submutants. AUIC and MPC information can provide guidance as to when low doses can be used, and when higher concentrations are required. This strategy can ensure efficacy, minimize toxicity, reduce the opportunity for resistance to occur, and save money. REFERENCES I. Paladino JA. Streamlining antibiotic therapy: clinical application of pharmacokinetic and pharmacodynamic principles. J Osteopath Med 1991; 5: 16-25. 2. Liss RH, Batchelor FR. Economic evaluations of antibiotic use and resistance - a perspective: report of task force 6. Rev Infect Dis 1987; 9 (suppI3): S297-312. 3. Holmberg SO, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987; 9: 1065-78. 4. Sanders cc. Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones. Clin Infect Dis 2001; 32(Suppl I ):S 1-8. 5. Ballow CH, Schentag 11. Trends in antibiotic utilization and bacterial resistance: report of the NNRSG. Diagn Microbiol Infect Dis. 1992; 15(suppl):37S-42S. 6. Rice LB, Eckstein EC, DeVente J, Shlaes OM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23: 118-24.
EAN: 9781402073076
Package Dimensions: 9.4 x 6.3 x 0.9 inches
Languages: English
